Codiak BioSciences

General Information


Codiak BioSciences is harnessing exosomes—natural intercellular messengers—to pioneer a new class of biologic medicines, exosome therapeutics. Exosomes are released and taken up by all cells and convey and protect complex biologically active molecules that can alter the function of recipient cells. Since exosomes are inherently non-immunogenic, we believe exosomes are an ideal solution for developing a broad spectrum of allogeneic therapies, or therapies derived from human cells that can be used in any patient.

Employees: 82
Founded: 2015
Contact Information
Address 500 Technology Square, 9th Floor, Cambridge, MA 02139, US
Phone Number (617) 949-4100
Web Address
View Prospectus: Codiak BioSciences
Financial Information
Market Cap
Revenues $0 mil (last 12 months)
Net Income $-62.0 mil (last 12 months)
IPO Profile
Symbol CDAK
Exchange NASDAQ
Shares (millions): 0.0
Price range $0.00 - $0.00
Est. $ Volume $86.3 mil
Manager / Joint Managers Jefferies, Evercore ISI, William Blair
CO-Managers Wedbush PacGrow
Expected To Trade:
Status: Withdrawn
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change